{"result": {"id": "362bd742-cf84-4112-a2d2-7d2eb212f86d", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Hypertensive Patients and LDL-C Management Community\",\n    \"summary\": \"This community focuses on the management of LDL-C (Low-Density Lipoprotein Cholesterol) levels in hypertensive patients to reduce cardiovascular risks. Key entities include hypertensive patients, LDL-C, and various lipid-lowering therapies such as statins, cholesterol absorption inhibitors, and small interfering RNA drugs. The relationships highlight the therapeutic strategies and clinical studies supporting the management of LDL-C levels in these patients.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical role of LDL-C management in preventing cardiovascular diseases in hypertensive patients.\",\n    \"findings\": [\n        {\n            \"summary\": \"Central role of LDL-C in cardiovascular risk management\",\n            \"explanation\": \"LDL-C is identified as the primary target for lipid-lowering therapy in hypertensive patients, underscoring its significance in cardiovascular risk reduction. Various therapies, including statins and cholesterol absorption inhibitors, are employed to manage LDL-C levels. [Data: Entities (1360), Relationships (1301, 1327, 4265, 4268, 4269, +more)]\"\n        },\n        {\n            \"summary\": \"Diverse therapeutic approaches for LDL-C reduction\",\n            \"explanation\": \"The community utilizes a range of therapeutic agents such as statins (e.g., Lovastatin, Pitavastatin), cholesterol absorption inhibitors (e.g., Ezetimibe, Hai Bo Mai Bu), and innovative treatments like small interfering RNA drugs and monoclonal antibodies (e.g., Evinacumab) to lower LDL-C levels. [Data: Entities (4424, 1375, 4412, 4479), Relationships (4265, 1327, 4253, 4341)]\"\n        },\n        {\n            \"summary\": \"Importance of clinical studies in guiding therapy\",\n            \"explanation\": \"Clinical studies such as the HOPE-3 study and the Polycap Study-3 provide evidence for the benefits of combined blood pressure and cholesterol management in reducing cardiovascular risks. These studies support the therapeutic strategies employed within the community. [Data: Entities (1367, 1368), Relationships (1311, 1312)]\"\n        },\n        {\n            \"summary\": \"Role of community doctors and primary healthcare institutions\",\n            \"explanation\": \"Community doctors and primary healthcare institutions play a crucial role in the screening, treatment, and long-term management of hypertensive patients, ensuring the effective implementation of LDL-C management strategies. [Data: Entities (1976, 1977), Relationships (2304, 2305)]\"\n        },\n        {\n            \"summary\": \"Innovative treatments targeting specific proteins\",\n            \"explanation\": \"Innovative treatments like Evinacumab target specific proteins such as angiopoietin-like protein 3 (ANGPTL3) to lower LDL-C levels, offering new avenues for managing patients with limited treatment options. [Data: Entities (4482, 4479), Relationships (4348, 4341)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560412, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 643, "prompt_tokens": 3380, "total_tokens": 4023, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1472}, "prompt_cache_hit_tokens": 1472, "prompt_cache_miss_tokens": 1908}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1359,高血压患者,Hypertensive patients who require combined blood pressure and lipid-lowering therapy to reduce cardiovascular risks>,14\n1360,LDL-C,\"**LDL-C (Low-Density Lipoprotein Cholesterol)** is commonly referred to as \"\"bad cholesterol\"\" due to its role in increasing the risk of cardiovascular disease. It is a key biomarker in cardiovascular health, as elevated levels can lead to buildup in the arteries, contributing to atherosclerosis and other cardiovascular conditions. LDL-C is the primary target for lipid-lowering therapies, including medications such as PCSK9 inhibitors (e.g., inclisiran), statins (e.g.,血脂康 [Xuezhikang]), and other treatments aimed at reducing its levels in hypertensive patients and those at risk for cardiovascular disease. The management of LDL-C is critical in preventing and mitigating cardiovascular risks.\",28\n4424,海博麦布,\"Hai Bo Mai Bu, a domestically developed cholesterol absorption inhibitor similar to ezetimibe>\",2\n4482,ANGIOPOIETIN-LIKE PROTEIN 3,\"\nA protein targeted by evinacumab to lower LDL-C levels\"\"\",2\n1375,EZETIMIBE,\"Ezetimibe is a cholesterol absorption inhibitor used alongside statins for LDL-C reduction\"\"\",1\n4412,SMALL INTERFERING RNA DRUGS,Small interfering RNA drugs are a newer class of medications that can help lower cholesterol levels by targeting specific genes involved in cholesterol metabolism,1\n4425,洛伐他汀,\"Lovastatin, a statin drug used for lowering cholesterol>\",1\n4426,匹伐他汀,\"Pitavastatin, a statin drug used for lowering cholesterol>\",1\n4427,普伐他汀,\"Pravastatin, a statin drug used for lowering cholesterol>\",1\n4428,辛伐他汀,\"Simvastatin, a statin drug used for lowering cholesterol>\",1\n1364,贝特类,\"Fibrates, used to treat high triglycerides in hypertensive patients to reduce pancreatitis risk>\",1\n1365,OMEGA-3多不饱和脂肪酸,\"Omega-3 polyunsaturated fatty acids, used alongside fibrates for triglyceride management>\",1\n1367,HOPE-3研究,\"HOPE-3 study, a clinical trial showing the cardiovascular benefits of combined blood pressure and cholesterol management>\",1\n1368,国际多效药物研究-3,\"Polycap Study-3, an international trial investigating the effects of multi-drug therapy on cardiovascular outcomes>\",1\n1976,社区医生,Medical professionals providing primary care and hypertension screening in communities,1\n1977,基层医疗卫生服务部门,\"Primary healthcare institutions responsible for hypertension detection, registration, treatment, and long-term management\",1\n1362,依折麦布,\"**依折麦布 (Ezetimibe)** is a cholesterol absorption inhibitor used to lower low-density lipoprotein cholesterol (LDL-C) levels. It is commonly administered in combination with statins to enhance LDL-C reduction. The medication works by inhibiting the absorption of cholesterol in the small intestine, thereby helping to manage elevated cholesterol levels. Both descriptions highlight its primary use in reducing LDL-C, whether as a standalone treatment or in conjunction with statins.  \n\nThe summary consolidates the information into a coherent description, emphasizing its mechanism of action and therapeutic application without contradictions.\",3\n4479,EVINACUMAB,\"Evinacumab is a monoclonal antibody designed to target angiopoietin-like protein 3 (ANGPTL3). It has been shown in phase 3 clinical trials to significantly reduce low-density lipoprotein cholesterol (LDL-C) levels. Evinacumab is specifically approved as a treatment for patients with homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder characterized by extremely high cholesterol levels. By inhibiting ANGPTL3, evinacumab helps lower cholesterol in individuals who have limited treatment options due to the severity of their condition.\",3\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n1301,高血压患者,LDL-C,Hypertensive patients require LDL-C as the primary target for lipid-lowering therapy,42\n1320,LDL-C,HDL-C,HDL-C is considered a secondary treatment target if LDL-C levels are already达标,37\n4265,LDL-C,海博麦布,Hai Bo Mai Bu is used to lower LDL-C levels by inhibiting cholesterol absorption,30\n4348,ANGIOPOIETIN-LIKE PROTEIN 3,LDL-C,Angiopoietin-like protein 3 affects LDL-C metabolism,30\n1327,LDL-C,EZETIMIBE,Ezetimibe is added to statins to further reduce LDL-C levels,29\n4253,LDL-C,SMALL INTERFERING RNA DRUGS,Small interfering RNA drugs can be used in combination with statins to further lower LDL-C levels,29\n4268,LDL-C,洛伐他汀,Lovastatin is a statin used to lower LDL-C levels,29\n4269,LDL-C,匹伐他汀,Pitavastatin is a statin used to lower LDL-C levels,29\n4270,LDL-C,普伐他汀,Pravastatin is a statin used to lower LDL-C levels,29\n4271,LDL-C,辛伐他汀,Simvastatin is a statin used to lower LDL-C levels,29\n1305,高血压患者,贝特类,Fibrates are used in hypertensive patients with high triglycerides to prevent pancreatitis,15\n1306,高血压患者,OMEGA-3多不饱和脂肪酸,Omega-3 fatty acids are combined with fibrates for triglyceride management in hypertensive patients,15\n1311,高血压患者,HOPE-3研究,The HOPE-3 study showed improved cardiovascular outcomes with combined blood pressure and cholesterol management,15\n1312,高血压患者,国际多效药物研究-3,The Polycap Study-3 investigated multi-drug approaches for cardiovascular risk reduction in hypertensive patients,15\n2304,社区医生,高血压患者,Community doctors provide screening and lifestyle guidance for hypertension patients,15\n2305,基层医疗卫生服务部门,高血压患者,Hypertension patients receive primary care and long-term management from grassroots medical institutions,15\n4279,依折麦布,海博麦布,Both are cholesterol absorption inhibitors with similar mechanisms of action,5\n4341,EVINACUMAB,ANGIOPOIETIN-LIKE PROTEIN 3,Evinacumab targets angiopoietin-like protein 3 to reduce LDL-C,5\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_6f09c3e8c052aed8fe86700b6bf0ebb97f55b03ca5c8732e83b27ac510959c83_v2"}